tenofovir_disoproxil_fumarate: profile and news
NGOs protest against AIDS drug patent May 11, 2006
...of Positive People registered their pre-grant opposition to a patent application filed by Gilead Sciences in India on Tenofovir Disoproxil Fumarate (TDF), a ... - Times of India,
Patent of AIDs Drug Opposed May 11, 2006
New Delhi, India (AHN) - Several groups have opposed the patent application of key AIDS drug Tenofovir Disoproxil Fumarate (TDF). ... - All Headline News
Additional oppn against AIDS drug patent May 13, 2006
...the company, one of the largest generics companies in India, which is already marketing a generic version of tenofovir (tenofovir disoproxil fumarate or Viread ... - Mid-Day Mumbai,
Patent Issue: AIDS shall cost dearer? May 14, 2006
...per Vineeta Pandey. Gilead has filed a patent application for Viread (tenofovir disoproxil fumarate) in India. Tenofovir is available ... - International Reporter,
US Drug Company Accused Of Making HIV Meds Unaffordable In India May 14, 2006
Gilead has applied for an Indian patent on the drug tenofovir, which has been available in India as the generic tenofovir disoproxil fumarate since last year. ... - 365Gay.com
Bristol-Myers Squibb en Gilead dienen aanvraag in bij FDA voor ... Apr 27, 2006
Application to US FDA for a Once-Daily Single Tablet Regimen of Sustiva(R) (Efavirenz) and Truvada(R) (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV ... - Netherlands Corporate News (persbericht),
MSF Supports Opposition To Gilead's Tenofovir Patent Application ... May 10, 2006
Indian civil society groups in their battle against a patent application by Gilead Sciences for the key AIDS drug tenofovir (tenofovir disoproxil fumarate, TDF ... - Doctors Without Borders,
Bristol-Myers Squibb and Gilead Sciences Submit New Drug ... Apr 27, 2006
HIV medications Sustiva(R) (efavirenz), manufactured by Bristol-Myers Squibb, and Truvada(R) (emtricitabine and tenofovir disoproxil fumarate), manufactured by ... - International News Service,
AIDS drug provokes patent battle in India May 11, 2006
AIDS registered a formal opposition Tuesday to a patent application by the US-based Gilead Sciences for the drug tenofovir disoproxil fumarate, commonly known ... - International Herald Tribune,
Indians march on parliament over Aids drug patent May 10, 2006
HIV/AIDS and the Delhi Network of Positive People this week registered a pre-grant opposition to the patenting of tenofovir disoproxil fumarate (Viread), an ... - Financial Times,
AIDS Drug Provokes Legal Fight in India Rights Group Sayspatent ... May 11, 2006
...a formal opposition Tuesday to a patent application in India by the US-based Gilead Sciences for the drug tenofovir disoproxil fumarate, commonly known just as ... - International News Service,
India drug challenge vital to poorest AIDS patients: health groups May 11, 2006
The suit against a patent application filed by California-based Gilead Sciences involves a drug called tenofovir disoproxil fumarate, which has fewer known ... - TODAYonline,
AHF APPLAUDS GILEAD SCIENCES FOR MOVE TO INCREASE GLOBAL ACCESS TO ... May 11, 2006
...that it is pursuing non-exclusive, voluntary licensing to generic manufacturers in India for its AIDS drug Viread (tenofovir disoproxil fumarate) and is ... - ITNews,
HIV Pharmacology Workshop: Explaining tenofovir renal toxicities ... May 2, 2006
...inhibitors (PIs). The prodrug form of tenofovir (tenofovir disoproxil fumarate) is delivered through the gut wall. Tenofovir is ... - Aidsmap,
Gilead Sciences Announces First Quarter 2006 Financial Results Apr 18, 2006
...by Gilead's HIV product franchise, including the continued robust performance of Truvada(R) (emtricitabine and tenofovir disoproxil fumarate) and Viread(R ... - Genetic Engineering News,
FDA asked to approve once-a-day HIV pill Apr 28, 2006
The product combines Bristol-Myers Squibb' anti-HIV medication Sustiva (efavirenz) and Gilead's Truvada (emtricitabine and tenofovir disoproxil fumarate). ... - Trenton Times,
Bristol-Myers Squibb Company Reports First Quarter 2006 Financial ... Apr 27, 2006
...a product that combines the company's anti-HIV medication SUSTIVA® (efavirenz), and Gilead's TRUVADA® (emtricitabine and tenofovir disoproxil fumarate), in a ... - Yahoo! News (press release)
Genzyme's First-Quarter Sales Below Expectations Apr 19, 2006
Credited for the good news were a boost in sales of the HIV therapies Viread (tenofovir disoproxil fumarate) and Truvada (a combination of Viread and ... - BioWorld Online (subscription),
Bristol-Myers Squibb Company Reports First Quarter 2006 Financial ... Apr 27, 2006
...product that combines the company's anti-HIV medication SUSTIVA(R) (efavirenz), and Gilead's TRUVADA(R) (emtricitabine and tenofovir disoproxil fumarate), in a ... - PR Newswire (press release),
Bristol-Myers, Gilead Sciences Seek FDA Nod for New HIV Drug Apr 27, 2006
...product combines the anti-HIV medications Sustiva (efavirenz) of Bristol-Myers Squibb and Truvada (emtricitabine and tenofovir disoproxil fumarate) of Gilead ... - Business New Jersey (subscription),
Bristol-Myers Squibb Company Reports First Quarter 2006 Financial ... Apr 27, 2006
...that combines the company’s anti-HIV medication SUSTIVA(R) (efavirenz), and Gilead’s TRUVADA(R) (emtricitabine and tenofovir disoproxil fumarate), in a once ... - WebWire (press release),
